Biosynthesis of O-N-Acetylglucosamine-linked Glycans in Trypanosoma cruzi
CHARACTERIZATION OF THE NOVEL URIDINE DIPHOSPHO-N-ACETYLGLUCOSAMINE:POLYPEPTIDE N-ACETYLGLUCOSAMINYLTRANSFERASE-CATALYZING FORMATION OF N-ACETYLGLUCOSAMINE alpha 1right-arrowO-THREONINE*

Jose O. PreviatoDagger , Mauro Sola-Penna§, Orlando A. AgrellosDagger , Christopher Jones, Thomas Oeltmannparallel , Luiz R. Travassos**, and Lucia Mendonça-PreviatoDagger Dagger Dagger

From the Dagger  Instituto de Microbiologia and § Faculdade de Farmácia, CCS-Bloco I, Universidade Federal do Rio de Janeiro, 21944 970 Cidade Universitária, Rio de Janeiro-RJ, Brazil,  Laboratory for Molecular Structure, National Institute for Biological Standard and Control, Potters Bar, Herts EN6 3QG, United Kingdom, parallel  Department of Molecular Biology, Vanderbilt University, Nashville, Tennessee 37235, and ** Disciplina de Biologia Celular, Universidade Federal de São Paulo, 04023 062, São Paulo-SP, Brazil

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In this study, we have characterized the activity of a uridine diphospho-N-acetylglucosamine:polypeptide-alpha -N-acetylglucosaminyltransferase (O-alpha -GlcNAc-transferase) from Trypanosoma cruzi. The activity is present in microsomal membranes and is responsible for the addition of O-linked alpha -N-acetylglucosamine to cell surface proteins. This preparation adds N-acetylglucosamine to a synthetic peptide KPPTTTTTTTTKPP containing the consensus threonine-rich dodecapeptide encoded by T. cruzi MUC gene (Di Noia, J. M., Sánchez D. O., and Frasch, A. C. C. (1995) J. Biol. Chem. 270, 24146-24149). Incorporation of N-[3H]acetylglucosamine is linearly dependent on incubation time and concentration of enzyme and substrate. The transferase activity has an optimal pH of 7.5- 8.5, requires Mn2+, is unaffected by tunicamycin or amphomycin, and is strongly inhibited by UDP. The optimized synthetic peptide acceptor for the cytosolic O-GlcNAc-transferase (YSDSPSTST) (Haltiwanger, R. S., Holt, G. D., and Hart, G. W. (1990) J. Biol. Chem. 265, 2563-2568) is not a substrate for this enzyme. The glycosylated KPPTTTTTTTTKPP product is susceptible to base-catalyzed beta -elimination, and the presence of N-acetylglucosamine alpha -linked to threonine is supported by enzymatic digestion and nuclear magnetic resonance data. These results describe a unique biosynthetic pathway for T. cruzi surface mucin-like molecules, with potential chemotherapeutic implications.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Trypanosoma cruzi is the causative agent of Chagas' disease, a multisystemic disorder endemic in much of Latin America. This protozoan has a complex life cycle involving morphologically distinct stages in mammalian and insect hosts. Blood-sucking triatomine bugs transmit infective trypomastigotes to the mammalian host, which multiply intracellularly as amastigotes prior to differentiation into trypomastigotes, which, after rupture of the host cell, enter the blood stream, enabling infection of fresh cells or ingestion by a feeding triatomine bug, thus completing the biological cycle of transmission (1). Antigenic glycoconjugates, including the highly O-glycosylated sialoglycoproteins, known as mucin-like molecules, have been strongly implicated in the molecular mechanism of attachment to and invasion of mammalian host cells (2). The sialic acid residues present in these molecules are derived from host sialoglycoconjugates (3) and are transferred to the T. cruzi surface glycoproteins by a unique trans-sialidase (4). The first evidence for O-glycosylation of serine and/or threonine in trypanosomal glycoproteins came from studies of T. cruzi GP-25 (5), a glycoprotein corresponding to the C-terminal domain of cruzipain (6). More recently, O-glycosylated mucin-like proteins were demonstrated in metacyclic (7) and cell-derived trypomastigotes (8) and in epimastigotes (9, 10). Structural analyses have shown that these O-glycans vary between strains and developmental stages (9-11).

The striking feature of these O-glycans is that they are linked to the peptide backbone through an N-acetylglucosamine (GlcNAc) unit, with threonine (Thr) rather than serine (Ser) being the usual site of attachment (10, 12). The GlcNAc-Thr core can be extended by addition of Galp, Galf, and sialic acid residues. These were the first O-GlcNAc-linked oligosaccharides reported in surface glycoproteins. Previously, single O-GlcNAc units linked to Ser and/or Thr have been described on nuclear and cytosolic glycoproteins (13). This post-translational modification on the nuclear and cytoplasmic proteins is catalyzed by a cytosolic O-GlcNAc-transferase (14).

The unusual addition of O-GlcNAc to T. cruzi surface glycoproteins prompted us to investigate this post-translational modification in more detail. In this paper, we describe a novel UDP-GlcNAc:polypeptide alpha -N-acetylglucosaminyltransferase from T. cruzi and specify the optimal conditions for its activity. We have also characterized the in vitro glycosylation products and have established the anomeric configuration of GlcNAc O-linked to Thr.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Materials-- Radioactively labeled UDP-[6-3H]GlcNAc (40-60 Ci/mmol), UDP-[6-3H]GalNAc (5-15 Ci/mmol), NaB[3H]4 (100-500 mCi/mmol), and [1-3H]glucose (10-30 Ci/mmol) were purchased from American Radiolabeled Chemicals, Inc. The radioactive sugar alcohols N-[1-3H]acetylglucosaminitol ([3H]GlcNAcO),1 N-[1-3H]acetylgalactosaminitol ([3H]GalNAcO), Galpbeta 1right-arrow4GlcNAcO[3H], and Galpbeta 1right-arrow6(Galpbeta 1right-arrow4)[3H]GlcNAcO were prepared by reduction of 10 µmol of saccharides with 10 µCi of NaB[3H]4 in water for 1 h at room temperature, followed by addition of 100 µmol of unlabeled NaBH4. Borate salts were removed by repeated addition of methanol and evaporation, passage through a mixed-bed ion exchange resin, and gel filtration on Bio-Gel P-4 (extra fine). The radioactive monosaccharides [6-3H]GlcN and [6-3H]GalN were prepared by hydrolysis of radioactive sugar nucleotides in 3 M HCl at 100 °C for 4 h. Unlabeled UDP-GlcNAc, SP Sephadex (SP-C25-120), and beta -N-acetylglucosaminidase from jack beans were obtained from Sigma. The peptides KPPTTTTTTTTKPP, YSDSPSTST, and YSPTSPSK (with the O-beta -GlcNAc on the serine at position 5) used in this study were kindly supplied by A. C. C. Frasch, R. S. Haltiwanger, and G. W. Hart, respectively. All other reagents were of the highest available quality.

Parasites-- The Y strain of T. cruzi was used in all enzymatic experiments. Native sialoglycoproteins were purified from epimastigotes of the Y, CL-Brener, and Dm28c strains. Epimastigotes were cultured at 28 °C in brain-heart infusion medium supplemented with hemin and 5% of fetal calf serum, and harvested in the exponential phase of growth (15). Trypomastigotes were obtained from LLC-MK2 cells infected with tissue culture-derived trypomastigotes for 6 days, maintained at 37 °C in RPMI medium containing 10% fetal calf serum, under 5% CO2 (8).

Microsomal Membrane Preparation-- Pellets of 2 × 1011 epimastigotes or 1.12 × 109 cell-derived trypomastigotes were ground in liquid nitrogen. The homogenate was diluted with 10-20 ml of 250 mM sucrose and 25 mM Tris/HCl, pH 7.4 (Tris/sucrose buffer), and centrifuged for 10 min at 12,000 × g. The supernatant was then ultracentrifuged for 1 h at 120,000 × g, and the resulting pellet was resuspended in Tris/sucrose buffer with a glass-Teflon homogenizer and ultracentrifuged as above. The pellet was then resuspended in Tris/sucrose buffer and appropriately diluted for protein assay (16).

Enzymatic Assay: O-alpha -GlcNAc-transferase Activity-- The standard assay contained, in a final volume of 50 µl, 25 mM Tris/HCl buffer (pH 7.4), 5 mM MgCl2, 5 mM MnCl2, 0.1% Triton X-100, 1.5 µCi of UDP-[3H]GlcNAc (40-60 Ci/mmol), and 6.8 nmol of synthetic peptide acceptor substrate (KPPTTTTTTTTKPP). The reaction was initiated by addition of microsomal membranes (250 µg of protein). Control assays without the acceptor peptide were used to correct for endogenous activity. The mixture was incubated at 28 °C for 30 min, and the reaction terminated by addition of 950 µl of 50 mM formic acid. The reaction mixture was loaded onto a 1-ml sulfopropyl-Sephadex column (SP-C 25-120) equilibrated in 50 mM formic acid. The column was washed with 5 ml of 50 mM formic acid, and the peptide and labeled glycopeptide were eluted with 4 ml of 0.5 M NaCl. Incorporation of [3H]GlcNAc into peptide was determined on aliquots of the eluate by liquid scintillation counting after addition of Bray solution (5 ml). In experiments to increase radiolabel incorporation, the reaction mixture (100 µl) contained 25 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 5 mM MnCl2, 15 µCi of UDP-[3H]GlcNAc, 6.8 nmol of acceptor peptide, and microsomal membranes (1 mg of protein). Other conditions and the method for the isolation of the labeled peptide were as described above. For testing of trypomastigote microsomal fraction, the reaction mixture (50 µl) contained 25 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 5 mM MnCl2, 1.5 µCi of UDP-[3H]GlcNAc, 3.4 nmol of acceptor peptide, and 25 µg (protein) of the microsome preparation. Other conditions were as described above.

Optimization of the O-alpha -GlcNAc-transferase Assay-- Incorporation of [3H]GlcNAc was measured at different temperatures (4, 20, 28, and 37 °C), different incubation times (10, 20, 30, 60 and 120 min), and in the presence of increasing concentrations of Triton (0.01-0.5%), the peptide substrate (0-34 nmol), and microsomes (100-300 µg of protein). The effect of pH on GlcNAc-transferase activity was assayed in Tris-MES buffer at pH 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, and 9.0 (final concentration in the reaction mixture, 50 mM) under standard incubation conditions. The synthetic peptide YSDSPSTST was used at 450 nmol and at 20 or 28 °C.

HPLC Purification of O-Glycosylated Peptide-- Incorporation of [3H]GlcNAc into synthetic peptide was confirmed by RP-HPLC on a C18 column (5 µm, 4 × 250 mm, Amersham Pharmacia Biotech) eluted with an H2O/acetonitrile/trifluoroacetic acid gradient. Solvent A was 0.1% aqueous trifluoroacetic acid, and solvent B was 0.089% trifluoroacetic acid in acetonitrile. The linear gradient was started 5 min after injection from 0 to 15% solvent B over 40 min (held until 50 min). The flow rate was 1 ml/min, and 0.8- or 1.0-ml fractions were collected. Aliquots were mixed with 5 ml of Bray solution, and the radioactivity was determined by liquid scintillation counting. Elution of unlabeled peptide was monitored by absorbance at 206 nm.

Analysis of the Reaction Product-- [3H]GlcNAc-labeled peptide fraction obtained by RP-HPLC was rechromatographed on Bio-Gel P-4 (extra fine) (120 cm × 0.5 cm) at 0.6 ml/h with 0.2 M ammonium acetate as the eluent. The column was calibrated using bovine serum albumin and [3H]glucose as marker for the void (vo) and included volumes, respectively. The elution positions of authentic standards of [3H]GlcNAcO, Galpbeta 1right-arrow4[3H]GlcNAcO, and Galpbeta 1right-arrow6(Galpbeta 1right-arrow4)[3H] GlcNAcO were also determined. Fractions of 300 µl were collected and assayed for radioactivity. The labeled peptide fraction was desalted, lyophilized, and dissolved in 10 mM NaOH, containing 0.3 M NaBH4, at 37 °C for 48 h to beta -eliminate and reduce saccharides linked to threonine (17). The solution was neutralized with M acetic acid and passed through Dowex 50W-X8 (25-50 mesh H+ form). Boric acid was removed by repeated evaporation with methanol. The residue was dissolved in distilled water and analyzed by gel filtration on Bio-Gel P-4 column (as described above) and by descending paper chromatography in ethyl acetate:pyridine:water (8:2:1) for 48 h (18). The distribution of radioactivity on the paper chromatogram was determined by cutting the paper strips into 1-cm sections and liquid scintillation counting.

In the experiment using a microsome preparation from trypomastigote forms, the [3H]GlcNAc-labeled peptide was submitted to acid hydrolysis in 3 M HCl, at 100 °C for 4 h; the HCl evaporated in vacuo, and the radiolabeled product was analyzed by descending paper chromatography in butanol:pyridine:0.1 M HCl (5:3:2) for 18 h (19).

Digestion with Jack Bean beta -N-Acetylglucosaminidase-- The reaction mixture for jack bean beta -N-acetylglucosaminidase digestion contained HPLC-purified [3H]GlcNAc-labeled peptide (approximately 5 × 104 cpm), 50 mM phosphate-citrate buffer, pH 5.0, and 0.8 units of enzyme in a final volume of 100 µl. The mixture was incubated at 37 °C for 18 h (20, 21), the reaction was terminated by addition of 900 µl of 50 mM formic acid, and the solution was loaded onto a 1-ml SP-Sephadex (25-120) column equilibrated in 50 mM formic acid. Released [3H]GlcNAc was eluted with 50 mM formic acid (5 ml), lyophilized, and the radioactivity was determined by liquid scintillation counting. p-Nitrophenyl N-acetyl-beta -D-glucosaminide was used as substrate control. As a further positive control, 100 µmol of the unlabeled synthetic glycopeptide YSPTSPSK, with the O-beta -GlcNAc on the serine at position 5 (kindly provided by G. W. Hart) was digested under identical conditions. The reaction was terminated by addition of 50 mM formic acid, and the liberated GlcNAc was recovered on SP-Sephadex as above and quantified using the Morgan-Elson reaction (22). A standard curve was constructed using D-GlcNAc similarly chromatographed on SP-Sephadex.

Preparation of GlcNAc-rich Glycopeptides from Native Sialoglycoproteins for NMR Spectroscopy-- Sialoglycoproteins from epimastigote forms were purified as described by Previato et al. (4). The sialoglycoproteins from T. cruzi CL-Brener strain were subjected to partial acid hydrolysis (0.2 M trifluoroacetic acid for 2 h at 100 °C). The GlcNAc-rich glycopeptides were recovered by gel filtration on a column of Sephadex G25 SF (1 × 10 cm). Also, GlcNAc-rich glycopeptides were obtained from Y, CL-Brener, and Dm28c sialoglycoproteins by Smith degradation (23). Briefly, to 2 ml of a solution containing 30 mg of T. cruzi sialoglycoproteins in 0.1 M sodium acetate (pH 4.6), an equal volume of 0.2 M NaIO4 was added. After 24 h at 4 °C, oxidation was terminated by addition of glycerol. The oxidized products were recovered by gel filtration on Sephadex G25 SF (1 × 10 cm) column, using water as eluent, at a flow rate of 1 ml/min. The oxidized glycoproteins were reduced with sodium borohydride for 3 h at room temperature. Boric acid was removed by repeated evaporation with methanol. The material, oxidized and reduced, was partially hydrolyzed with 20 mM trifluoroacetic acid for 30 min at 100 °C. The resulting GlcNAc-rich glycopeptides were recovered by gel filtration on Sephadex G25 SF as above.

NMR Analysis of the GlcNAc-rich Glycopeptides-- NMR spectra were acquired on a Varian Unity 500 NMR spectrometer equipped with a 5-mm PFG (pulsed field gradient) triple resonance probe and at indicated probe temperatures of 30 or 40 °C. Standard pulse sequences were used except for the introduction of an echo sequence into the ROESY and TOCSY spectra and WHSQC pulse sequence, which is an implementation of the method of Wider and Wüthrich (24). The mixing time in the TOCSY spectra was 80 and 150 ms in the ROESY spectra. Presaturation of the residual water signal was achieved using a low power pulse from the transmitter. In the WHSQC spectra, obtained at 500 MHz, heteronuclear decoupling was achieved using the GARP sequence. 1H and 13C chemical shifts were referenced to internal 3-(trimethylsilyl)tetra-deuteropropionic acid at zero ppm (1H) and -1.8 ppm (13C, to tetramethylsilane at zero) (25).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Development of an Assay for T. cruzi O-alpha -GlcNAc-transferase: Optimization of Assay Conditions-- An assay for O-GlcNAc-transferase activity was developed using microsomal membranes prepared from epimastigotes of the Y strain of T. cruzi. To measure the transfer of GlcNAc in vitro, UDP-[6-3H]GlcNAc was used as the GlcNAc donor and the synthetic peptide KPPTTTTTTTTKPP as acceptor. This peptide was chosen due to its similarity with a common motif in the peptide sequence of deglycosylated sialoglycoproteins from the Y strain2 and the MUC gene family products from T. cruzi (26). KPPTTTTTTTTKPP proved to be successful as a substrate for T. cruzi GlcNAc-transferase activity. As shown in Fig. 1, the incorporation of [3H]GlcNAc into the peptide was time dependent for a period up to 2 h (Fig. 1A) and was proportional to increasing amounts of protein (using a microsomal membrane preparation as the enzyme source) (Fig. 1B) and of the peptide acceptor (Fig. 1C). The standard assay was performed at 28 °C, although a similar rate was observed at 20 °C. At 37 °C, the activity was slightly less than that observed at 4 °C (Fig. 1A).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of incubation time and substrate concentration on the activity of T. cruzi O-alpha -GlcNAc-transferase. T. cruzi O-alpha -GlcNAc-transferase activity, in the standard assay, as a function of (A) incubation time at different temperatures (4, 20, 28, 37 °C); B, enzyme concentration, reported as the amount of protein in the microsomal preparation; C, amount of synthetic peptide acceptor KPPTTTTTTTKPP; D, transferase activity was assayed at different pH levels in Tris-MES buffer. The assays were performed as described under "Experimental Procedures."

Effect of Inhibitors-- Addition of 5 mM UDP reduced incorporation of [3H]GlcNAc into the synthetic peptide by 90%. Transferase activity was not reduced in the presence of tunicamycin or amphomycin, even when added at 10 µg/ml.

Ion Dependence and Optimum pH-- The transferase was inactive in the absence of metal ions, but activity was regained by adding Mn2+. Table I shows that among seven divalent cations tested, Mn2+ was the most effective in restoring activity. Co2+ and Ca2+ were able to restore 20 and 15% of the activity observed in the presence of Mn2+. The O-GlcNAc-transferase activity had a pH optimum between 7.5 and 8.5, with maximum activity at pH 8.5. Activity decreased gradually below pH 7.0 and above pH 8.5, with only 50% of the activity at pH 8.5 present at pH 9.0 (Fig. 1D).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Effect of divalent cations on the activity of T. cruzi O-alpha -GlcNAc transferase

Characterization of the Glycosylated Peptide Product-- The radiolabeled material recovered from the SP-Sephadex column was characterized by several techniques. A single peak of radioactivity was obtained after reversed phase HPLC on a C18 column with an elution volume distinct from that of the unlabeled peptide acceptor substrate (Fig. 2A). Bio-Gel P-4 chromatography of this radiolabeled material indicated that its apparent molecular mass was greater than that of the unlabeled peptide acceptor (Fig. 2B). After base-catalyzed beta -elimination and reduction of the purified radiolabeled glycopeptide, radioactive material eluted at the same volume as authentic N-acetylhexosaminitol on the P-4 column (Fig. 2C), and its identity was confirmed as [3H]GlcNAcO by descending paper chromatography (Fig. 2D). In assays using larger amounts of UDP-[3H]GlcNAc, two radiolabeled fractions were observed in RP-HPLC (Fig. 3A) and on the P-4 column (Fig. 3B). One fraction showed a chromatographic profile identical with that of the glycopeptide obtained under standard conditions (Fig. 2, A and B). The other fraction was assumed to be a glycopeptide substituted with more than one GlcNAc residue (Fig. 3, A and B), as both fractions liberated [3H]GlcNAcO (identified by descending paper chromatography) on reductive beta -elimination (Fig. 3C).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Characterization of the reaction products from in vitro glycosylation of KPPTTTTTTTTKPP by T. cruzi O-alpha -GlcNAc-transferase. RP-HPLC (A) and gel filtration chromatography (B) on a P-4 column of the [3H]GlcNAc-labeled peptide are shown. The arrows indicate the elution position of BSA (vo), the unlabeled peptide acceptor, [3H]Glc (1), [3H]GlcNAcO (2), (Galpbeta 1right-arrow4)[3H]GlcNAcO (3), and Galpbeta 1right-arrow6(Galpbeta 1right-arrow4)[3H]GlcNAcO (4). The P-4 purified material, as shown in B, was subjected to beta -elimination and reduction, and the product was analyzed by Bio-Gel P-4 chromatography (C) (the arrows indicate the elution positions of the standards used in B and by descending paper chromatography in ethyl acetate:pyridine:water (8:2:1) (D) (the arrows indicate the migration positions of [3H]GlcNAcO and [3H]GalNAcO). Other experimental details are described under "Experimental Procedures."


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   Product characterization of two glycosylation sites into the peptide KPPTTTTTTTTKPP. Purification by RP-HPLC (A) and gel filtration chromatography (B) on Bio-Gel P-4 of heavily labeled synthetic peptide acceptor KPPTTTTTTTTPPK. Fractions I and II in A indicate different degrees of glycosylation and are related to the fractions I and II in B. C, descending paper chromatography of [3H]GlcNAcO derived from [3H]GlcNAc-labeled peptides from fractions I or II, after beta -elimination and reduction. The elution positions of standards BSA (vo), the unlabeled peptide acceptor, [3H]Glc (1), [3H]GlcNAcO (2), (Galpbeta 1right-arrow4)[3H] GlcNAcO (3), and Galpbeta 1right-arrow6(Galpbeta 1right-arrow4)[3H]GlcNAcO (4) are indicated. Other experimental details are described under "Experimental Procedures."

To investigate whether cell-derived trypomastigotes of T. cruzi also express the O-GlcNAc-transferase activity, a microsomal preparation from 109 trypomastigotes was tested. This fraction catalyzed the synthesis of SP-Sephadex-retained radioactive material, which coeluted with the "epimastigote" glycopeptide in RP-HPLC (Fig. 4A). After acid hydrolysis, the radioactive product was identified as [3H]GlcN by descending paper chromatography (Fig. 4B).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Characterization of the reaction product from in vitro glycosylation of KPPTTTTTTTTKPP by T. cruzi O-alpha -GlcNAc-transferase (trypomastigote forms). A, purification by RP-HPLC of [3H]GlcNAc-labeled peptide derived from incubation of a microsome preparation with 109 T. cruzi trypomastigotes. The arrow indicates the elution position of unlabeled peptide. B, Descending paper chromatography in butanol:pyridine:0.1 M HCl (5:3:2) of [3H]GlcN derived from [3H]GlcNAc-labeled glycopeptide after acid hydrolysis. The migration positions of standards [3H]GlcN and [3H]GalN are indicated. The experiment was performed as described under "Experimental Procedures."

Determination of the Anomeric Configuration of the GlcNAc O-Linked to Thr-- The anomeric configuration of the GlcNAc-Thr linkage was determined by enzymatic and NMR experiments. Treatment of the HPLC-purified [3H]GlcNAc-labeled peptide with beta -N-acetylglucosaminidase from jack beans failed to release [3H]GlcNAc from the glycopeptide, indicating that GlcNAc is not beta -linked to Thr. A glycopeptide YSPTSPSK with the O-beta -GlcNAc on the Ser at position 5 was used as a positive control and liberated between 50 and 55% GlcNAc when digested under identical conditions.

The anomeric configuration of the GlcNAc O-linked to Thr in glycopeptide prepared from the purified mucin by dilute acid hydrolysis (CL-Brener strain) or Smith degradation (Y, CL-Brener, and Dm28c strains) was determined by high field NMR spectroscopy. The spectra from all these samples were effectively identical. Fig. 5 shows expansions of the TOCSY (Fig. 5A) and ROESY (Fig. 5B) of the GlcNAc-rich glycopeptide from Y strain. The resonances between 4.4 and 5.4 ppm (Fig. 5A) were assigned to saccharide anomeric protons. The most intense of these originate from the O-linked glycans. Those between 4.44 and 4.53 ppm displayed a pattern of cross-peaks in the TOCSY spectrum typical of beta -Galp spin systems, (3JH3,H4 small and H-4 at low field) (9). The anomeric protons from the GlcNAc O-linked to Thr resonated between 4.75 and 4.95 ppm, with the most intense at 4.75 ppm. This chemical shift dispersity is presumably attributable to heterogeneous substitution by GlcNAc on the peptide backbone and to the presence of galactosylation of some GlcNAc residues.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 5.   Partial TOCSY and ROESY spectra of T. cruzi GlcNAc-rich glycopeptides. Partial 500 MHz TOCSY (A) and ROESY (B) spectra of GlcNAc-rich glycopeptides derived from T. cruzi Y strain sialoglycoproteins. The spectra were obtained at 40 °C, using an 80-ms mixing time for the TOCSY and 150 ms for the ROESY spectra. The spectral regions are numbered as follows: 1, GlcNAcbeta 1right-arrowNAsn H-1 trace; 2, Manbeta 1right-arrow4 H-1 trace; 3, Manalpha 1right-arrow 6 H-1 trace; 4, cross-peaks arising from correlations between the GlcNAc H-1 and ring protons; 5, cross-peaks arising from beta -Galp residues attached to the GlcNAcalpha 1right-arrowOThr. The group of peaks labeled 6 in the ROESY spectrum (B) are through-space correlations between the GlcNAc H-1 and Thr Hbeta .

Because glycopeptide from strain Dm28c was available in greatest quantity, WHSQC spectra with and without heteronuclear decoupling were recorded from this material (Fig. 6), which enabled partial assignment of the 13C spectrum and determination of the value of one bond proton carbon-coupling constants (1JC1,H1). N-Acetyl amino sugars are easily recognized by the high field positions of the C-2 resonance in their 13C spectra, which are observed at approximately 51.4 and 56.1 ppm for the methyl glycosides of GlcNAc and GalNAc, respectively (27). In the WHSQC spectrum of the GlcNAc-rich glycopeptide from Dm28c, the resonance at 54.6 ppm was assigned as C-2 of GlcNAc and was correlated to an H-2 resonance at 3.85 ppm, which in turn was correlated to anomeric proton resonances between 4.75 and 4.95 ppm in the TOCSY (Fig. 5A) and COSY spectra, which were thus unambiguously assigned as H-1 of GlcNAc. The corresponding anomeric carbons resonated between 99.5 and 99.9 ppm (from the same WHSQC spectrum) (Fig. 6, A and B).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 6.   Partial WHSQC spectra of T. cruzi GlcNAc-rich glycopeptide. Partial WHSQC spectra of the Dm28c GlcNAc-rich glycopeptide. A, trace through spectrum (B) at the chemical shift of the major GlcNAc C-1 resonance (arrow), showing the 171 Hz splitting of the major GlcNAc H-1 resonance. B, carbon-coupled spectrum showing resonance split by 1JH1,C1. This spectrum was obtained at 600 MHz. C, the anomeric region of the carbon-decoupled spectrum, with resonances labeled as follows: 1, Galpbeta 1right-arrow4; 2, right-arrow4GlcNAc(2)beta 1right-arrow4; 3, beta -Man; 4, alpha -Man; 5, GlcNAcalpha 1right-arrowOThr (2, 3, and 4 result from the high mannose chain). The cross-peak at 4.64 and 105.5 ppm is tentatively assigned to beta -Galp residues in extended O-linked oligosaccharide chains. This spectrum was obtained at 500 MHz.

In the ROESY spectrum (Fig. 5B), NOEs were observed from the most intense GlcNAc H-1 resonance at 4.75 ppm and the N-acetyl methyl resonances to Hbeta and methyl resonances of Thr, indicating linkage of the GlcNAc to Thr in the peptide backbone.

Some minor resonances, not attributable to the O-linked glycans, were also present. One set had chemical shifts for the H-1, C-1, and other structural reporter groups consistent with those reported for high mannose chains (28, 29), although only a Man2(GlcNAc)2 stub was present in the Smith-degraded samples (Fig. 5A).

The anomeric configuration of the GlcNAc residue was assigned from the values of the 3JH1,H2 and 1JH1,C1 coupling constants, the pattern of intra-residue NOEs, and the proton and the carbon shifts of the GlcNAc residues. The value of 3JH1,H2 in the GlcNAc residue was estimated as 3-4 Hz from resolved cross-peaks observed in the ROESY spectrum (Fig. 7C). This is consistent with the alpha -configuration (H-1 and H-2 gauche) (30), as a value of 8 Hz would be expected for GlcNAcbeta 1right-arrowOThr (in which H-1 and H-2 have a trans diaxial orientation), as was observed for the GlcNAcbeta right-arrowAsn present in the stub of the high mannose oligosaccharide chain (Fig. 7A). The value of 1JH1,C1 for the GlcNAc1right-arrowOThr was determined from the WHSQC spectrum, obtained at 600 MHz without heteronuclear decoupling (Fig. 6B). The magnitude of this coupling constant depends principally on the orientation of the anomeric proton and is typically 160 and 170 Hz for axial and equatorial H-1 values, respectively (i.e. for beta  and alpha  linkages in the case of a D-hexopyrananose in the 4C1 conformation) (31, 32). A value of 171 Hz was observed for 1JH1,C1 of GlcNAc H-1 (Fig. 6A), confirming an alpha  linkage whereas for the beta  -Galp resonances the measured value was 161 Hz.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 7.   Expansion of selected cross-peaks from TOCSY and ROESY spectra of T. cruzi GlcNAc-rich glycopeptide. Partial 500 MHz proton NMR spectra of selected cross-peaks, showing the 8 Hz 1JH1,H2 coupling for the right-arrow4GlcNAcbeta 1right-arrowNAsn residue of the high mannose chain (A). B, the unresolved 1JH1,H2 coupling of Manalpha 1right-arrow, typically 1.8 Hz; C, the 3JH1,H2 coupling of the GlcNAcalpha 1right-arrow1OThr, estimated at 3-4 Hz. A and B are expansions of the TOCSY spectrum of GlcNAc-rich glycopeptides obtained from partial acid hydrolysis of CL-Brener strain sialoglycoproteins, whereas C is from the ROESY spectrum of the same compound. All spectra were collected at 30 °C.

The only significant NOE observed between the GlcNAc H-1 to other protons on the saccharide ring was to the H-2, which is characteristic of the alpha -glyco configuration. In contrast, beta -glyco systems typically show strong intra-residue NOEs to H-3 and H-5.

No data for GlcNAcalpha 1right-arrowOThr containing model compounds have been reported, but in glycopeptides containing GlcNAcbeta 1right-arrowO-linked to Ser (33, 34) or Thr (34, 35), the chemical shift of the GlcNAc H-1 is in the range 4.40 to 4.57 ppm, clearly different from the values observed in the T. cruzi glycopeptides. The shifts for the alpha -GlcNAc H-1 resonances are unusually high field compared with alpha -GlcNAc in oligosaccharides (where the value is typically >5 ppm) but are consistent with the high field location of the GalNAcalpha 1right-arrowOThr anomeric proton in model systems for mammalian mucin, where published values are in the range 4.87-4.92 ppm (36, 37). The observed values for the GlcNAc residue in the T. cruzi mucin are thus in better agreement with an alpha - rather than a beta -linkage. Other proton chemical shifts were in agreement with this assignment. The carbon chemical shifts of the GlcNAc C-1 resonances were in the range 99.5-99.9 ppm (Fig. 6), as expected for the alpha -configuration.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

We have previously characterized a novel series of O-GlcNAc-linked oligosaccharides from surface sialoglycoproteins of T. cruzi (9, 10). The first step in the biosynthesis of these O-glycan chains is attachment of GlcNAc to the peptide backbone. In the present study, we show that microsomal membrane preparations from epimastigotes and trypomastigotes of T. cruzi Y strain have an O-alpha -GlcNAc-transferase that attaches GlcNAc to threonine in a suitable acceptor peptide. We used several approaches to define the activity of this enzyme and to assess its relationship to the cytosolic O-GlcNAc-transferase (14, 38).

We demonstrate that the synthetic peptide KPPTTTTTTTTKPP can function as acceptor for this novel transferase. This peptide incorporates a threonine-rich sequence, originally reported by DiNoia et al. (26), who showed that TTTTTTTTKPP is a common repeating motif in T. cruzi MUC gene products. The locations of the glycosylated threonines were not identified, but the peptide was a good substrate for in vitro glycosylation, at least two GlcNAc residues being incorporated in heavily labeled experiments. The nonapeptide YSDSPSTST, described by Haltiwanger et al. (38) as an optimum substrate for the cytosolic O-GlcNAc-transferase, was not glycosylated by the T. cruzi enzyme. UDP-[3H]GlcNAc was the activated GlcNAc donor in the T. cruzi system. Potentially, the mechanism of the reaction could be either direct transfer from UDP-GlcNAc or via formation of activated dolichol donors. To distinguish between these possibilities, the transferase activity was assayed in the presence of excess UDP and with the antibiotics tunicamycin or amphomycin, which are potent inhibitors of Dol-P-dependent glycosylation (39, 40). Only UDP abolished incorporation of [3H]GlcNAc into the acceptor peptide, indicating that UDP-GlcNAc acts directly as the GlcNAc donor. The cytosolic O-GlcNAc-transferase (38) also uses sugar nucleotides directly as sugar donors.

The T. cruzi enzyme, in common with most glycosyltransferases (41), requires divalent metal cations for activity, with Mn2+ being the most effective. This is in contrast to the cytosolic O-GlcNAc-transferase, which shows no metal ion dependence (38). Other differences between the T. cruzi microsomal enzyme and the ubiquitous cytosolic O-GlcNAc-transferase are that the former has an optimal pH range of 7.5-8.5, remains active at 37 °C, and has increased activity when treated with Triton X-100. Most strikingly, the T. cruzi enzyme attaches GlcNAc to the hydroxylated amino acid via an alpha -linkage, whereas the anomeric specificity of the cytosolic enzyme is beta . In support of this, the [3H]GlcNAc peptide (produced in vitro) was not susceptible to digestion of with beta -N-acetylglucosaminidase from jack beans, although under identical digestion conditions GlcNAc was readily liberated from unlabeled synthetic YSPTSPSK (with the O-beta -GlcNAc on the serine at position 5), corresponding to a sequence from the C-terminal repeat domain of the large subunit of RNA polymerase II (42), which in vivo is glycosylated by the cytosolic transferase. It is unlikely that the lack of susceptibility of the [3H]GlcNAc-K2P4T8 peptide to beta -N-acetylglucosaminidase is attributable to its amino acid sequence, as the jack bean enzyme is able to deglycosylate a diverse range of structurally distinct glycoproteins and glycopeptides, including sequences from nuclear pore protein, human erythrocyte band 4.1 protein, and the 65-kDa erythrocyte cytosolic protein (38, 42). More compellingly, NMR analysis of GlcNAc-rich glycopeptides from the native sialoglycoconjugates of T. cruzi showed unambiguously that the GlcNAc residue linked to Thr has the alpha -anomeric configuration, the 1JC, H, NOE, and chemical shift data all being consistent with the alpha - rather than the beta -anomer.

O-GlcNAc has previously been reported in surface glycoproteins from Plasmodium falciparum (43) and Giardia lamblia (44). Subsequent studies, however, showed that O-linked GlcNAc is either absent or present only at very low levels in P. falciparum (45) and that glucose rather than N-acetylglucosamine is the O-linked sugar in G. lamblia (46). Because the O-GlcNAc-transferase activity of T. cruzi is associated with the microsomal fraction, and because its known natural substrates are GPI-anchored N-linked surface glycoproteins (10), it seems likely that it is associated with some compartment of the secretory pathway, although confirmation of this must await completion of detailed localization studies. Because the enzyme differs in its anomeric specificity, kinetic properties, and possibly in cellular location from the cytosolic enzyme described in higher eukaryotes, it may prove to be unique to T. cruzi. If so, it constitutes an exciting potential target for the rational design of novel chemotherapeutic agents. Purification of the transferase is currently in progress and should soon enable these questions to be addressed.

    ACKNOWLEDGEMENTS

We thank Dr. A. C. C. Frasch and Dr. J. M. DiNoia (Instituto de Investigaciones Biotecnologicas, UNSAM, San Martin, Provincia de Buenos Aires, Argentina), Dr. R. Haltiwanger (Dept. of Biochemistry, SUNY, Stony Brook, NY), and Prof. G. W. Hart (Johns Hopkins University School of Medicine, Baltimore) for the synthetic peptides. Also, we thank Dr. R. Wait for critical reading of the manuscript, X. Lemercinier for the 13C-coupled WHSQC spectrum, the MRC Biomedical NMR Center for access to the Unity 600 NMR spectrometer, and the Sir Halley Stewart Trust for funding.

    FOOTNOTES

* This work was supported by grants from Programa Núcleo de Excelência, Financiadora de Estudos e Projetos, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Conselho de Ensino para Graduados, and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Dagger A Howard Hughes International Research Scholar. To whom correspondence should be addressed. Tel.: 55-21-5903093; Fax: 55-21-2708647; E-mail: immglup{at}microbio.ufrj.br.

1 The abbreviations used are: [3H]GlcNAcO, N-[1-3H]acetylglucosaminitol; [3H]GalNAcO, N-[1-3H]acetylgalactosaminitol; MES, 2-(N-morpholino)ethanesulfonic acid; Galf, galactofuranose; Galp, galactopyranose; HPLC, high performance liquid chromatography; ROESY, rotating frame nuclear Overhauser enhancement sprectroscopy; RP, reverse phase; TOCSY, total correlation spectroscopy; NOE, nuclear Overhauser enhancement.

2 J. O. Previato and L. Mendonça-Previato, unpublished results.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Brener, Z. (1973) Annu. Rev. Microbiol. 27, 347-382[CrossRef][Medline] [Order article via Infotrieve]
  2. Burleigh, B. A., and Andrews, N. W. (1995) Annu. Rev. Microbiol. 49, 175-200[CrossRef][Medline] [Order article via Infotrieve]
  3. Previato, J. O., Andrade, A. F. B., Dos Reis, G. A., and Mendonça-Previato, L. (1991) Mem. Inst. Oswaldo Cruz 86, Suppl. I, 53-54
  4. Previato, J. O., Andrade, A. F. B., Pessolani, M. C. V., and Mendonça-Previato, L. (1985) Mol. Biochem. Parasitol. 16, 85-96[CrossRef][Medline] [Order article via Infotrieve]
  5. Mendonça-Previato, L., Gorin, P. A. J., Braga, A. F., Scharfstein, J., and Previato, J. O. (1983) Biochemistry 22, 4980-4987[Medline] [Order article via Infotrieve]
  6. Cazzulo, J. J., Stoka, V., and Turk, V. (1997) Biochemistry 378, 1-10[CrossRef]
  7. Schenkman, S., Ferguson, M. A. J., Heise, N., Cardoso de Almeida, M. L., Mortara, R. A., and Yoshida, N. (1993) Mol. Biochem. Parasitol. 59, 293-304[CrossRef][Medline] [Order article via Infotrieve]
  8. Almeida, I., Ferguson, M. A. J., Schenkman, S., and Travassos, L. R. (1994) Biochem. J. 304, 793-802[Medline] [Order article via Infotrieve]
  9. Previato, J. O., Jones, C., Gonçalves, L. P. B., Wait, R., Travassos, L. R., and Mendonça-Previato, L. (1994) Biochem. J. 301, 151-159[Medline] [Order article via Infotrieve]
  10. Previato, J. O., Jones, C., Xavier, M. T., Wait, R., Travassos, L. R., Parodi, A. J., and Mendonça-Previato, L. (1995) J. Biol. Chem. 270, 7241-7250[Abstract/Free Full Text]
  11. Serrano, A. A., Schenkman, S., Yoshida, N., Mehler, A., Richardson, J. M., and Ferguson, M. A. J. (1995) J. Biol. Chem. 270, 27244-27253[Abstract/Free Full Text]
  12. DiNoia, J. M., Pollevick, G. D., Xavier, M. T., Previato, J. O., Mendonça-Previato, L., Sánches, D. O., and Frasch, A. C. C. (1996) J. Biol. Chem. 271, 32078-32083[Abstract/Free Full Text]
  13. Hart, G. W., Kreppel, L. K., Comer, F. I., Arnold, C. S., Snow, D. M., Ye, Z., Cheng, X., Dellamanna, D., Caine, D. S., Earles, J., Akimoto, Y., Cole, R. N., and Hayes, B. K. (1996) Glycobiology 6, 711-716[Medline] [Order article via Infotrieve]
  14. Haltiwanger, R. S., Blomberg, M. A., and Hart, G. W. (1992) J. Biol. Chem. 267, 9005-9013[Abstract/Free Full Text]
  15. Previato, J. O., Gorin, P. A. J., Mazurek, M., Xavier, M. T., Fournet, B., Wieruszesk, J. M., and Mendonça-Previato, L. (1990) J. Biol. Chem. 265, 2518-2526[Abstract/Free Full Text]
  16. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275[Free Full Text]
  17. Yen, P. H., and Ballou, C. E. (1974) Biochemistry 13, 2420-2427[Medline] [Order article via Infotrieve]
  18. Do, K.-Y., Do, S.-I., and Cummings, R. D. (1997) Glycobiology 7, 183-194[Abstract]
  19. Got, R., Cheftel, R.-I., Font, J., and Moretti, J. (1967) Biochim. Biophys. Acta 136, 320-330[Medline] [Order article via Infotrieve]
  20. Holt, G. D., Snow, C. M., Senior, A., Haltiwanger, R. S., Gerace, L., and Hart, G. W. (1987) J. Cell Biol. 104, 1157-1164[Abstract]
  21. Hanover, J. A., Cohen, C. K., Willinghan, M. C., and Park, M. K. (1987) J. Biol. Chem. 262, 9887-9894[Abstract/Free Full Text]
  22. Dische, Z. (1962) Methods Carbohydr. Chem. 1, 507-512
  23. Goldstein, I. J., Hay, G. W., Lewis, B. A., and Smith, F. (1965) Methods Carbohydr. Chem. 5, 361-370
  24. Wider, G., and Wüthrich, K. (1993) J. Magn. Reson. 102, 239-241[CrossRef]
  25. Wishart, D., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield, E., Markley, J. L., and Sykes, B. D. (1995) J. Biomol. NMR 6, 135-140[Medline] [Order article via Infotrieve]
  26. DiNoia, J. M., Sánchez, D. O., and Frasch, A. C. C. (1995) J. Biol. Chem. 270, 24146-24149[Abstract/Free Full Text]
  27. Bock, K., and Pedersen, C. (1983) Adv. Carbohydr. Chem. Biochem. 41, 27-66
  28. Lu, J., and Van Halbeek, H. (1996) Carbohydr. Res. 296, 1-21[CrossRef][Medline] [Order article via Infotrieve]
  29. Vliegenthart, J. F. G., Dorland, L., and Kamerling, J. P. (1983) Adv. Carbohydr. Chem. Biochem. 41, 209-373
  30. Dabrowski, J. (1994) in Two Dimensional NMR Spectroscopy Applications for Chemistry and Biochemistry (Croasmun, W. R., and Carlson, R. M. K., eds), VCH, New York
  31. Bock, K., and Pedersen, C. (1974) J. Chem. Soc. Perkin Trans. II, 293-297
  32. Tvaroska, I., and Taravel, F. R. (1995) Adv. Carbohydr. Chem. Biochem. 51, 15-61[Medline] [Order article via Infotrieve]
  33. Pao, Y.-L., Wormald, M. R., Dwek, R. A., and Lellouch, A. C. (1996) Biochem. Biophys. Res. Commun. 219, 157-162[CrossRef][Medline] [Order article via Infotrieve]
  34. Saha, U. K., Griffiths, L. S., Rademann, J., Geyer, A., and Schmidt, R. R. (1997) Carbohydr. Res. 304, 233-239
  35. Seitz, O., and Wong, C.-H. (1997) J. Am. Chem. Soc. 119, 8766-8776[CrossRef]
  36. Davoust, D., Platzer, N., Derappe, C., Lemonnier, M., Ferrar, B., and Pavia, A. A. (1985) Carbohydr. Res. 143, 233-239[CrossRef][Medline] [Order article via Infotrieve]
  37. Klich, G., Paulsen, H., Meyer, B., Meldal, M., and Bock, K. (1997) Carbohydr. Res. 299, 33-48[CrossRef][Medline] [Order article via Infotrieve]
  38. Haltiwanger, R. S., Holt, G. D., and Hart, G. W. (1990) J. Biol. Chem. 265, 2563-2568[Abstract/Free Full Text]
  39. Ericson, M. C., Gafford, J. T., and Elbein, A. D. (1977) J. Biol. Chem. 252, 7431-7433[Abstract]
  40. Banerjee, D. K., Scher, M. G., and Waechter, C. J. (1981) Biochemistry 20, 1561-1568[Medline] [Order article via Infotrieve]
  41. Schachter, H., and Brockhausen, I. (1992) in Glycoconjugates (Allen, H. J., and Kisailus, E. C., eds), pp. 263-332, Marcel Dekker, Inc., New York
  42. Hart, G. W., Kelly, W. G., Blomberg, M. A., Roquemore, E. P., Dong, L.,-Y., Kreppel, L., Chou, T-Y., Snow, D., and Greis, K. (1993) Colloquium Mosbach 44, 91-103
  43. Dieckmann-Schuppert, A., Bause, E., and Schwarz, R. T. (1993) Eur. J. Biochem. 216, 779-788[Abstract]
  44. Ortega-Barria, E., Ward, H. D., Evans, J. E., and Pereira, M. E. A. (1990) Mol. Biochem. Parasitol. 43, 151-166[Medline] [Order article via Infotrieve]
  45. Gowda, D. C., Gupta, P., and Davidson, E. A. (1997) J. Biol. Chem. 272, 6428-6439[Abstract/Free Full Text]
  46. Papanastasiou, P., McConville, M. J., Hülsmeir, A., Ralton, J., Hiltpold, A., and Köhler, P. (1997) Glycoconjugate J. 14, Suppl. 1, S55


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.